Skip to main content

Table 5 PRKAA1 Polymorphisms with clinical outcome of patients with NGCA

From: Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer

Genotype All patients NGCA
HR (95% CI) p-Value HR (95% CI) p-Value HR (95% CI)a p-Value HR (95% CI)b p-Value
rs10074991
 AA Reference   Reference   Reference   Reference  
 AG 1.16(0.87,1.55) 0.300 1.62(1.10,2.38) 0.015 1.63(1.10,2.41) 0.015 1.80(1.21,2.67) 0.004
 GG 1.15(0.83,1.59) 0.401 1.64(1.08,2.49) 0.020 1.71(1.12,2.60) 0.012 1.75(1.13,2.70) 0.012
 AG/GG 1.16(0.88,1.52) 0.290 1.62(1.12,2.35) 0.011 1.66(1.14,2.41) 0.008 1.78(1.21,2.61) 0.003
rs13361707
 TT Reference   Reference   Reference   Reference  
 TC 1.18(0.89,1.57) 0.253 1.67(1.13,2.47) 0.010 1.68(1.13,2.50) 0.010 1.85(1.24,2.77) 0.003
 CC 1.16(0.84,1.61) 0.364 1.68(1.10,2.56) 0.016 1.76(1.15,2.68) 0.009 1.79(1.16,2.78) 0.009
 TC/CC 1.18(0.90,1.54) 0.246 1.67(1.15,2.44) 0.007 1.71(1.17,2.50) 0.006 1.83(1.24,2.70) 0.002
rs154268
 TT Reference   Reference      
 TC 1.08(0.85,1.36) 0.525 1.18(0.90,1.56) 0.242     
 CC 1.23(0.78,1.94) 0.367 1.29(0.78,2.12) 0.322     
 TC/CC 1.10(0.88,1.17) 0.405 1.20(0.92,1.56) 0.183     
rs6882903
 CC Reference   Reference      
 CA 0.97(0.76,1.24) 0.796 1.12(0.84,1.48) 0.443     
 AA 1.48(0.89,2.47) 0.130 1.56(0.90,2.72) 0.113     
 CA/AA 1.02(0.81,1.29) 0.869 1.17(0.89,1.53) 0.252     
rs3805490
 TT Reference   Reference      
 TA 1.03(0.82,1.30) 0.807 1.07(0.81,1.41) 0.626     
 AA 0.82(0.51,1.31) 0.404 0.97(0.55,1.68) 0.898     
 TA/AA 0.99(0.80,1.24) 0.953 1.06(0.81,1.37) 0.691     
rs461404
 AA Reference   Reference      
 GA 1.08(0.86,1.37) 0.506 1.19(0.90,1.56) 0.352     
 GG 1.25(0.80,1.94) 0.333 1.31(0.80,2.13) 0.228     
 GA/GG 1.11(0.89,1.38) 0.379 1.21(0.93,1.57) 0.165